Sponsored by:

Nuclear Medicine: Page 389

Neoprobe hires Linder
Radiopharmaceutical probe developer Neoprobe has hired Richard Linder, Jr. as vice president of sales and marketing.
October 26, 2003
Amersham re-ups with Novation
By AuntMinnie.com staff writers
Amersham Health has received a new contract from group purchasing organization Novation.
October 23, 2003
Digirad achieves profitability
By AuntMinnie.com staff writers
For the period ended September 30, San Diego-based Digirad said it achieved its first profitable quarter since it began generating revenue in 1998.
October 21, 2003
Fujisawa, Bristol-Myers Squibb ink promotion deal
By AuntMinnie.com staff writers
Bristol-Myers Squibb Medical Imaging and Fujisawa Healthcare have entered into a co-promotion agreement in the U.S. for Fujisawa’s Adenoscan.
October 20, 2003
Detection of occult metastases in head and neck cancer feasible with SLN biopsy
By Edward Susman
Sentinel nodes can be readily identified during head and neck surgery by using a radionuclide-labeled colloid, according to presenters at the 2003 American Academy of Otolaryngology-Head and Neck Surgery Foundation meeting in Orlando, FL. In addition, careful dissection of the nodes appears to correlate with full neck dissection.
October 19, 2003
GE rumored to be courting Amersham
By AuntMinnie.com staff writers
GE Medical Systems parent General Electric has reportedly made an overture to British pharmaceutical firm Amersham, according to an article in the Wall Street Journal.
October 9, 2003
Nuclear medicine specialists find success with corn-fed cholescintigraphy
By Shalmali Pal
Dr. Grant Eiselen and Dr. Stephen Ferrante at Rochester General Hospital in New York turned to dietary corn for diagnosing gallbladder dyskinesia when the synthetic form of cholecystokinin (CCK) became unavailable.
October 2, 2003
2003 10 03 06 10 11 706
Draxis scores patent
By AuntMinnie.com staff writers
Radiopharmaceutical developer DraxImage has received a U.S. patent for a family of chelating compounds that could be used in the development of imaging and radiotherapeutic agents.
October 1, 2003
Molecular Imaging Radiology Insider
By Jonathan S. Batchelor
Physicians who diagnose gall bladder dyskinesia will remember 2001 as the year Bristol-Myers Squibb turned off the tap on Kinevac, a synthetic cholecystokinin drug used in cholescintigraphy. A year later, in December 2002, Bracco Diagnostics resumed manufacturing and marketing the product.
September 28, 2003
Philips adds molecular imaging partnership
By AuntMinnie.com staff writers
Philips Medical Systems parent Royal Philips Electronics has formed a molecular imaging collaboration with biotechnology company CellPoint.
September 28, 2003
IPL releases cobalt-57 flood source
By AuntMinnie.com staff writers
Nuclear medicine developer Isotope Products Laboratories is scheduled to begin shipments of a cobalt-57 flood source, Perflexion, the first week of October.
September 28, 2003
Cardinal Health gets 510(k), NVLAP accreditation
By AuntMinnie.com staff writers
Healthcare firm Cardinal Health of Dublin, OH, said its Nuclear Associates subsidiary has received U. S. Food and Drug Administration 510(k) clearance for its CalRad Mark VI Dose Calibrator.
September 24, 2003
Previous Page
Page 389 of 440
Next Page